An essential resource for all cardiologists, internists, and medical residents, Pharmacological Management of Hypertension and Dyslipidemia assists clinicians in the treatment of hypertension and high cholesterol, the two most easily diagnosed and treatable risk factors for cardiovascular disease. This concise yet complete handbook includes the scientific background for each drug class presented, and includes a review of the science supporting the utilization of the agents in particular patient situations. The medications and their doses and dosage forms are presented in easy to use tables, so that the practitioners can quickly access the information to make their treatment decisions, whether they are in the hospital or in an outpatient setting.

An essential resource for all cardiologists, internists, and medical residents, Pharmacological Management of Hypertension and Dyslipidemia assists clinicians in the treatment of hypertension and high cholesterol, the two most easily diagnosed and treatable risk factors for cardiovascular disease. This concise yet complete handbook includes the scientific background for each drug class presented, and includes a review of the science supporting the utilization of the agents in particular patient situations. The medications and their doses and dosage forms are presented in easy to use tables, so that the practitioners can quickly access the information to make their treatment decisions, whether they are in the hospital or in an outpatient setting.

Dyslipidemia Essentials integrates the latest clinical guidelines and trials into a practical step-by-step guide to the management of dyslipidemia. Important clinical trials, common management pitfalls, and other cardiovascular risk reduction measures are also emphasized.

Now in its thoroughly updated Third Edition, the Hypertension Primer is a comprehensive, readable source of state-of-the-art scientific and clinical information on hypertension. The book contains more than 150 short chapters by distinguished experts that cover every aspect of hypertension and its pathogenesis, epidemiology, impact, and management. The chapters are grouped into three well-organized sections--basic science, population science, and clinical management--and each chapter is cross-referenced to other relevant chapters. Each chapter is easily digestible and begins with a bulleted list of key points.

Cardiovascular, respiratory, and related conditions cause more than 40 percent of all deaths globally, and their substantial burden is rising, particularly in low- and middle-income countries (LMICs). Their burden extends well beyond health effects to include significant economic and societal consequences. Most of these conditions are related, share risk factors, and have common control measures at the clinical, population, and policy levels. Lives can be extended and improved when these diseases are prevented, detected, and managed. This volume summarizes current knowledge and presents evidence-based interventions that are effective, cost-effective, and scalable in LMICs.